In developing countries, poor glycemic control among their diabetic population remains a major challenge. This study explored the potential of 90 days Diabefly® program towards improving glycemic control in people with type 2 diabetes and demonstrated an effective mean reduction of HbA1c, body weight and BMI by 1.63%, 2.38 kg, and 0.83 kg/m2 respectively. Thus, Diabefly® program aids in improving glycemic control and subsequently reduces the risk of diabetes-related complications.